| Tretinoin | Approved Investigational Nutraceutical | EIF2S3 | 1968 |
downregulated | Tretinoin results in decreased expression of EIF2S3 mRNA | Xp22.11 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF2S3 | 1968 |
upregulated | Tretinoin results in increased expression of EIF2S3 mRNA | Xp22.11 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF3A | 8661 |
downregulated | Tretinoin results in decreased expression of EIF3A mRNA | 10q26.11 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF3B | 8662 |
downregulated | Tretinoin results in decreased expression of EIF3B mRNA | 7p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF3C | 8663 |
downregulated | Tretinoin results in decreased expression of EIF3C mRNA | 16p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF4A2 | 1974 |
downregulated | Tretinoin results in decreased expression of EIF4A2 mRNA | 3q27.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF4A2 | 1974 |
upregulated | Tretinoin results in increased expression of EIF4A2 mRNA | 3q27.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF4B | 1975 |
downregulated | Tretinoin results in decreased expression of EIF4B mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF4E | 1977 |
downregulated | Tretinoin results in decreased expression of EIF4E mRNA | 4q23 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF4EBP1 | 1978 |
downregulated | Tretinoin results in decreased expression of EIF4EBP1 mRNA | 8p11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF4EBP2 | 1979 |
downregulated | Tretinoin metabolite results in decreased expression of EIF4EBP2 mRNA | 10q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF4EBP2 | 1979 |
downregulated | Tretinoin results in decreased expression of EIF4EBP2 mRNA | 10q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF4G1 | 1981 |
upregulated | Tretinoin results in increased expression of EIF4G1 mRNA | 3q27.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF4G2 | 1982 |
upregulated | Tretinoin results in increased expression of EIF4G2 mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF4G3 | 8672 |
upregulated | Tretinoin results in increased expression of EIF4G3 mRNA | 1p36.12 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF5A | 1984 |
downregulated | Tretinoin results in decreased expression of EIF5A mRNA | 17p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF5A2 | 56648 |
downregulated | Tretinoin results in decreased expression of EIF5A2 mRNA | 3q26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ELAC2 | 60528 |
downregulated | Tretinoin results in decreased expression of ELAC2 mRNA | 17p12 | |
| Tretinoin | Approved Investigational Nutraceutical | ELAVL1 | 1994 |
downregulated | Tretinoin results in decreased expression of ELAVL1 mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ELAVL4 | 1996 |
upregulated | Tretinoin results in increased expression of ELAVL4 mRNA | 1p33-p32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ELF3 | 1999 |
upregulated | Tretinoin results in increased expression of ELF3 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ELF4 | 2000 |
downregulated | Tretinoin results in decreased expression of ELF4 mRNA | Xq26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ELF4 | 2000 |
upregulated | Tretinoin results in increased expression of ELF4 mRNA | Xq26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ELK3 | 2004 |
upregulated | Tretinoin results in increased expression of ELK3 mRNA | 12q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ELK4 | 2005 |
downregulated | Tretinoin results in decreased expression of ELK4 mRNA | 1q32.1 | |